HRP20080452T3 - Farmaceutski pripravak koji se raspada u ustima isadrži risperidon - Google Patents

Farmaceutski pripravak koji se raspada u ustima isadrži risperidon

Info

Publication number
HRP20080452T3
HRP20080452T3 HR20080452T HRP20080452T HRP20080452T3 HR P20080452 T3 HRP20080452 T3 HR P20080452T3 HR 20080452 T HR20080452 T HR 20080452T HR P20080452 T HRP20080452 T HR P20080452T HR P20080452 T3 HRP20080452 T3 HR P20080452T3
Authority
HR
Croatia
Prior art keywords
risperidon
outs
pharmaceutical preparation
risperidone
polymethacrylate
Prior art date
Application number
HR20080452T
Other languages
English (en)
Inventor
Kroselj Vesna
Rajer Tadeja
Rangus Marija
Gustin Jozica
Original Assignee
Krka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Krka filed Critical Krka
Publication of HRP20080452T3 publication Critical patent/HRP20080452T3/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Farmaceutski pripravak koji se raspada u ustima koji sadržia) risperidon ili njegovu sol ili solvat, b) polimetakrilat, c) šećerni alkohol, ted) sredstvo za raspadanje, koje sadrži (i) umreženi polivinilpirolidon i (ii) niskosupstituiranu hidroksipropilcelulozu. Patent sadrži još 15 patentnih zahtjeva.
HR20080452T 2004-06-15 2005-06-14 Farmaceutski pripravak koji se raspada u ustima isadrži risperidon HRP20080452T3 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102004028940A DE102004028940A1 (de) 2004-06-15 2004-06-15 Oral zerfallende pharmazeutische Zusammensetzung, die Risperidon enthält
PCT/EP2005/006375 WO2005123084A1 (en) 2004-06-15 2005-06-14 Orally disintegrating pharmaceutical composition comprising risperidone

Publications (1)

Publication Number Publication Date
HRP20080452T3 true HRP20080452T3 (hr) 2008-10-31

Family

ID=34971693

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20080452T HRP20080452T3 (hr) 2004-06-15 2005-06-14 Farmaceutski pripravak koji se raspada u ustima isadrži risperidon

Country Status (13)

Country Link
EP (1) EP1768673B1 (hr)
AT (1) ATE402706T1 (hr)
DE (2) DE102004028940A1 (hr)
EA (1) EA010178B1 (hr)
ES (1) ES2311230T3 (hr)
HR (1) HRP20080452T3 (hr)
NO (1) NO20070187L (hr)
PL (1) PL1768673T3 (hr)
PT (1) PT1768673E (hr)
RS (1) RS50609B (hr)
SI (1) SI1768673T1 (hr)
UA (1) UA87692C2 (hr)
WO (1) WO2005123084A1 (hr)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20080085310A1 (en) * 2006-10-06 2008-04-10 Maria Oksana Bachynsky Capecitabine rapidly disintegrating tablets
TW200835527A (en) * 2006-12-26 2008-09-01 Shionogi & Co Orally disintegrating tablet and bitter taste-masked formulation comprising risperidone
CN101269014B (zh) * 2007-03-21 2012-11-14 江苏万特制药有限公司 一种利培酮的口腔崩解片及其制备方法
WO2008152729A1 (ja) * 2007-06-15 2008-12-18 Teikokumedix Co., Ltd. リスペリドンを含むゼリー状の医薬組成物
CN101485636B (zh) * 2008-01-14 2010-12-22 齐鲁制药有限公司 利培酮口腔崩解片及其制备方法
WO2013095314A1 (en) * 2011-12-19 2013-06-27 Mahmut Bilgic Pharmaceutical formulations comprising risperidone
WO2013100876A1 (en) * 2011-12-27 2013-07-04 Mahmut Bilgic Risperidone formulations

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2172793T3 (es) * 1996-06-17 2002-10-01 Janssen Pharmaceutica Nv Formas de dosificacion biconvexas de desintegracion rapida.
US7919119B2 (en) * 1999-05-27 2011-04-05 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
WO2003009831A1 (fr) * 2001-07-27 2003-02-06 Yamanouchi Pharmaceutical Co., Ltd. Compositions contenant des grains fins a liberation prolongee pour comprimes a desagregation rapide dans la cavite buccale et procede de production associe
US20040265375A1 (en) * 2003-04-16 2004-12-30 Platteeuw Johannes J. Orally disintegrating tablets
EP1620075B1 (en) * 2003-05-07 2020-06-24 Samyang Biopharmaceuticals Corporation Highly plastic granules for making fast melting tablets
WO2005120463A1 (en) * 2004-06-09 2005-12-22 Ranbaxy Laboratories Limited Rapidly disintegrating tablets of risperidone

Also Published As

Publication number Publication date
EP1768673B1 (en) 2008-07-30
EA200700023A1 (ru) 2007-06-29
EA010178B1 (ru) 2008-06-30
NO20070187L (no) 2007-03-02
ES2311230T3 (es) 2009-02-01
PL1768673T3 (pl) 2009-01-30
WO2005123084A1 (en) 2005-12-29
ATE402706T1 (de) 2008-08-15
UA87692C2 (ru) 2009-08-10
PT1768673E (pt) 2008-10-21
RS50609B (sr) 2010-06-30
DE102004028940A1 (de) 2006-01-12
DE602005008607D1 (de) 2008-09-11
EP1768673A1 (en) 2007-04-04
SI1768673T1 (sl) 2008-12-31

Similar Documents

Publication Publication Date Title
IS2580B (is) Platínuafleiða lyfjasamsetningar
NO20033556L (no) Farmasöytiske formuleringer
ATE392863T1 (de) Streifen zur abgabe eines mundpflegewirkstoffes
NO20043998L (no) Oral administreringsform for tungtloselige basiske aktive virkestoffer
EE05081B1 (et) Farmatseutilised kompositsioonid, mis sisaldavad 3-aminoasetidiini derivaate, 3-aminoasetidiini derivaadid ja nende valmistamise meetodid
KR20050009999A (ko) 약제학적 제제
EE05104B1 (et) Asetidiini derivaadid, nende valmistamise meetodid ja farmatseutiline kompositsioon
NO20033384D0 (no) Farmasöytisk formulering
DE60307677D1 (de) Dispergierbare pharmazeutische zusammensetzungen
HN2003000054A (es) Formas de dosificacion farmaceutica de liberacion controlada de un inhibidor de la proteina de transferencia de ester de colesterilo (cetpi), a procedimientos de uso y a procedimientos de preparacion de las mismas.
NO20033785D0 (no) Farmasöytisk formulering
NO20040356L (no) Indaneddiksyrederivater og deres andvendelse som farmasoytiske midler, intermediater og fremgangsmate for fremstilling.
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
CY1110906T1 (el) Φαρμακευτικη συνθεση για ρινικη χορηγηση φεντανυλης
NO20035627D0 (no) Farmasöytisk formulering
EE05385B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensotiasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁvalmistamismeetodÁjaÁkasutamineÁningÁfarmatseutilineÁkompositsioon
DK1643976T3 (da) Farmaceutisk formulering omfattende levothyroxinnatrium
ITRM20030363A0 (it) Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse.
DE60217390D1 (de) Bicalutamid enthaltende pharmazeutische zusammensetzung
HRP20080452T3 (hr) Farmaceutski pripravak koji se raspada u ustima isadrži risperidon
NO20041485L (no) Farmasoytisk formulering omfattende (R)-bicalutamid
EE05384B1 (et) LaiaspektrilisedÁ2-(asendatudÁamino)bensoksasoolsulfoonamiididÁkuiÁHIVÁproteaasiÁinhibiitorid,ÁnendeÁkasutamine,ÁfarmatseutilineÁkompositsioonÁjaÁmeetodÁretroviiruseÁreplikatsiooniÁinhibeerimiseks
NO20042890L (no) Farmasoytiske preparater og fremgangsmate for fremstilling derav
MXPA01011842A (es) Composiciones farmaceuticas para la administracion oral de floroglucinol y preparacion de las mismas.
NO20043007L (no) Farmasoytisk suspensjon for oral administrering